🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Owens & Minor Q3 earnings beat estimates, revenue up 5% YoY

EditorRachael Rajan
Published 11/04/2024, 06:56 AM
© Reuters.
OMI
-

RICHMOND, Va. - Owens & Minor, Inc. (NYSE:OMI) reported third-quarter earnings that exceeded analyst expectations, with revenue growing 5% year-over-year, driven by solid demand in its Patient Direct and Medical Distribution segments.

OMI shares were up 0.75% following the announcement Monday.

The healthcare solutions company posted adjusted earnings per share of $0.42, beating the analyst consensus of $0.41. Revenue for the quarter came in at $2.72 billion, surpassing estimates of $2.68 billion and representing a 5% increase from the same period last year.

Owens & Minor's Patient Direct segment saw revenue rise 6% to $687 million compared to the third quarter of 2023, fueled by strength in diabetes and sleep supplies. The Products & Healthcare Services (NASDAQ:HCSG) segment revenue grew 5% to $2.0 billion, driven primarily by strong same-store sales in Medical Distribution.

"Our third quarter results demonstrated our ability to deliver on our commitments both near-term as well as on our strategic initiatives," said Edward A. Pesicka, President & CEO of Owens & Minor.

The company reported a GAAP net loss of $13 million, or -$0.17 per share, for the quarter. Adjusted EBITDA increased 5% year-over-year to $142 million.

Owens & Minor reduced its total debt by $198 million in the third quarter, including full redemption of its 2024 senior notes.

For the full year 2024, the company narrowed its guidance, now expecting adjusted EPS between $1.45 and $1.55, compared to the analyst consensus of $1.59. Revenue is projected to be in the range of $10.6 billion to $10.8 billion.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.